Skip to main content

BioShares Biotechnology Clinical Trials ETF (BBC)

NYSEARCA: BBC · IEX Real-Time Price · USD
48.48 1.16 (2.45%)
Sep 23, 2021 4:00 PM EDT - Market closed
Expense Ratio0.79%
PE Ration/a
Shares Out850,000
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend DateDec 20, 2017
1-Year Return
Previous Close47.32
Day's Range47.89 - 48.51
52-Week Low37.18
52-Week High62.60
Inception DateDec 16, 2014

About BBC

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Asset ClassPortfolio-Multi Asset
RegionNorth America
Stock ExchangeNYSEARCA
Ticker SymbolBBC
Index TrackedBioShares Biotechnology Clinical Trials Index

Top 10 Holdings

11.20% of assets
Cerevel TherapeuticsCERE1.28%
Bny Mellon Cash Reserve UsdN/A1.25%
Kadmon HoldingsKDMN1.20%
Dynavax TechnologiesDVAX1.17%
Celldex TherapeuticsCLDX1.12%
Intellia TherapeuticsNTLA0.95%
View More Holdings


Ex-DividendAmountPay Date
Dec 20, 2017$0.29724Dec 27, 2017
Dec 21, 2015$0.14733Dec 29, 2015
Full Dividend History


Biotech Stocks Have Colds, but They Can Heal

This year hasn't been kind to biotechnology stocks and related exchange traded funds. The headwinds faced by these assets were ratcheted up last week when the Biden administration revealed plans to purs...

Other symbols:SBIOBBHIBB
1 week ago - ETF Trends

Finding Synergy With SPY

Looking for the perfect partner for the world's largest ETF.

3 weeks ago - ETFcom

Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News

The FDA granted full approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech that could accelerate inoculations in the United States.

1 month ago - Zacks Investment Research

Should Investors Follow Private Equity into Life Sciences?

Reflecting what it considers the vast potential of life sciences companies, Bain Capital is making another huge bet on the industry. The Boston-based investment firm has raised $1.9 billion in a new fun...

1 month ago - GuruFocus

Biotech ETFs Surge on Biogen's Alzheimer Drug Approval

The approval for Biogen's Alzheimer's disease treatment has spread strong optimism, with many investors pulling in capital to this high growth and high beta sector.

3 months ago - Zacks Investment Research

Healthcare ETFs Pop on Bristol Myers-MyoKardia Deal

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

11 months ago - Zacks Investment Research

Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

1 year ago - Zacks Investment Research

Why Small-Cap Biotech ETFs Are Good Long-Term Bets

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

Other symbols:BTECIBBJIDNA
1 year ago - Zacks Investment Research

Betting on Biotech With Utility Beyond Covid-19

The ALPS Medical Breakthroughs ETF (SBIO) is one of many biotechnology ETF garnering attention this year amid the race to defeat the coronavirus, but SBIO also offers investors allure that will extend b...

Other symbols:IBBSBIO
1 year ago - ETF Trends

Biotech ETFs Gain Amid Vaccine Optimism

With a slew of news to start off the month and quarter, biotech equities and ETFs are moving higher on Wednesday with optimism over developments on the coronavirus vaccine front. The Dow Jones Industria...

Other symbols:BBHIBB
1 year ago - ETF Trends

3 ETFs With Q2 Gains Of At Least 30%

The S&P 500 is sitting on an impressive 16.36% gain with just one day left in the second quarter.

Other symbols:ACESARGT
1 year ago - Benzinga

Biotech ETFs in the Spotlight, Why They’ll Remain There

Biotechnology ETFs, including the ALPS Medical Breakthroughs ETF (SBIO), are on torrid paces in the second quarter. Yes, some of that bullishness is attributable to the industry’s efforts to vanquish th...

Other symbols:IBBSBIO
1 year ago - ETF Trends

4 Best ETF Charts of Q1 Earnings

Below are four ETFs that buoyed up on strong earnings results.

Other symbols:IBUYITBWCLD
1 year ago - Zacks Investment Research

Biotech ETF (BBC) Hits a New 52-Week High

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

1 year ago - Zacks Investment Research

Biotechnology Sector ETFs Are Leading the Charge

Biotechnology sector-related exchange traded funds led the charge on Monday, with some breaking out to new highs. Among the best performing non-leveraged ETFs of Monday, the ARK Genomic Revolution ETF (...

Other symbols:XBI
1 year ago - ETF Trends

3 Biotech ETFs Up 10% Or More Over The Last Month

Something's been brewing in the health care sector, the second-largest group in the S&P 500.

Other symbols:ARKGBTEC
1 year ago - Benzinga

Failure to Launch: The ETF Built to Fight the Coronavirus That Never Came to Be

Bloomberg's Eric Balchunas and Scarlet Fu break down the Virtus LifeSci Biotech Clinical Trials ETF (ticker: BBC) with Paul Yook, CIO of LifeSci Venture Partners.

1 year ago - Bloomberg Markets and Finance

Best Growth ETFs for Q1 2020

The best Growth ETFs for Q1 2020 are XLK, BBC, and VGT.

Other symbols:VGTXLK
1 year ago - Investopedia

Best Healthcare ETFs for Q1 2020

The best Healthcare ETFs for Q1 2020 are BBC, SBIO, and KURE.

Other symbols:KURESBIO
1 year ago - Investopedia

Biotech ETFs Are Not Riding the Wave from Coronavirus Panic

Despite concerns of a spreading coronavirus out of China, biotechnology stocks and sector-related ETFs are not enjoying the usual bump on hopes of developing new treatments to counter the contagion. Amo...

Other symbols:IBBXBI
1 year ago - ETF Trends

3 of the Best Biotech ETFs on the Market

These biotech ETFs could be standouts again in 2020, particularly if genomics stocks rally

Other symbols:ARKGPBE
1 year ago - InvestorPlace

5 Market-Beating Smart-Beta ETF Charts of 2019

These smart-beta ETFs beat the broader market with ease in 2019.

Other symbols:FTXLGOAUQTUM
1 year ago - Zacks Investment Research

5 Best ETFs Of 2019

With just two trading days left in 2019, the SPDR S&P 500 ETF, the world's largest exchange traded fund, is higher by 29.19% this year, meaning the S&P 500 is on pace for its best annual performance sin...

1 year ago - Benzinga

Biotech Rally Sends Nasdaq to 9000: ETFs in Focus

Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.

Other symbols:XPH
1 year ago - Zacks Investment Research